NCT01449539终止不适用
Pilot Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 8
- 试验地点
- 2
- 主要终点
- Number of Stem Cells Collected
研究概览
简要总结
The purpose of this study is to evaluate the safety and efficacy of hyperbaric oxygen therapy (HBOT) as a therapeutic option in mobilizing stem cells for autologous stem cell transplant.
详细描述
Subjects will receive HBOT daily for 10 days in conjunction with standard growth factor treatment regimens for stem cell mobilization. The role of HBOT in stem cell mobilization as well as its role on oxidative stress will be evaluated.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are being considered for autologous stem cell transplant as part of their routine care who have failed at least one prior attempt at stem cell mobilization with any of currently available standard regimens using growth factors.
- •Patients in who the use of Mozobil® is medically justified but is not possible because of insurance or financial reasons
- •Patients scheduled to begin standard growth factor treatment with Neupogen® as part of routine care.
- •Patients who have had a bone marrow evaluation performed within one month prior to enrollment as part of routine clinical care or under IRB#
- •Patients who have had a chest x-ray or CT Chest within 60 days prior to enrollment.
- •ECOG performance status ≤ 3 performed within 60 days prior to enrollment which will be determined by history.
- •Patients who are at least 18 years of age at the time of registration.
- •Patient must have signed an IRB-approved informed consent and understand the investigational nature of the study.
排除标准
- •Clinically significant hepatic dysfunction as noted by direct bilirubin or AST >3 times the upper normal limit or clinically significant concurrent hepatitis within 60 days prior to enrollment.
- •History of New York Heart Association (NYHA) Class III or Class IV heart failure
- •Recent (< 6 months) myocardial infarction, unstable angina, difficult to control congestive heart failure, uncontrolled hypertension, or difficult to control cardiac arrhythmias from medical history.
- •Untreated pneumothorax from medical history.
- •Uncontrolled seizure disorder from medical history
- •Uncontrolled insulin dependent diabetes (verified by routine labs in medical record)
- •History of severe claustrophobia
- •Severe COPD (FEV1 < 50% of predicted on pulmonary function test) performed within 60 days prior to enrollment
- •Untreated ear barotraumas from medical history
- •Pregnancy or currently breastfeeding (females of childbearing potential must agree to use adequate contraception during the study). A urine pregnancy test will be performed prior to initiating HBOT.
- •Patients currently receiving Bleomycin, Cisplatin, Disulfiram, Doxorubicin, and Sulfamylon.
- •Any other condition that the PI determines may jeopardize the safety of the subject during the course of the study
结局指标
主要结局
Number of Stem Cells Collected
时间窗: one week post-treatment
Total stem cells collected from all participants at one week post-study treatment
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
招募中
不适用
Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver DiseasesMetabolic Dysfunction-associated Steatotic Liver DiseaseHepatic SteatosisNon-alcoholic Fatty Liver DiseasesNCT06619808Jinling Hospital, China150
招募中
1 期
Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) TransplantMyelodysplastic SyndromesAcute Myeloid LeukemiaAtypical Chronic Myeloid LeukemiaChronic Monocytic LeukemiaMyelodysplastic/Myeloproliferative NeoplasmMyelofibrosisChronic Myelomonocytic LeukemiaNCT03964506Omar Aljitawi24
Unknown
不适用
The Effectiveness of Hyperbaric Oxygen Therapy on Pneumonia Complicating StrokeHyperbaric Oxygen TherapyStrokePneumoniaNCT04376359Ya Zhang168
已完成
3 期
Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With AutismAutismNCT00584480University of California, San Francisco10
已完成
不适用
The Influence of Hyperbaric Oxygen in Patients With Perianal Crohn's Disease Already Treated With TNF Alpha Blockers Treated With TNF Alpha BlockersPerianal FistulasCrohn's DiseaseNCT01828190Assaf-Harofeh Medical Center50